Crowdonomics
All companies
OS SALUTEM (OSSA) logo

OS SALUTEM (OSSA)

Operating

Os Salutem LLC

Healthcare · Founded 2020

Oral health beauty regimen to address inflammation effectively and naturally

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$53,200
Across 1 round since 2023

Financials

FY2021–FY2023 · from SEC filings · hover any figure for its source
$0
2021
$0
−$156K
2022
$3K
−$20K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 unaudited*
FY2022 unaudited
FY2023 unaudited
Income statement
Revenue
$0
$0
$3,126
Cost of goods sold
$0
$0
$312
Gross margin
—
—
90%
Net income
$0
-$155,840
-$19,744
Taxes paid
$0
$900
$178
Balance sheet
Cash
$0
$52,000
$52,000
Accounts receivable
$0
$0
$0
Total assets
$0
$127,060
$120,220
Short-term debt
$0
$228,900
$67,817
Long-term debt
$0
$0
$0
Total liabilities
$0
$228,900
$67,817
Other
Headcount
—
1
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Raised $53.2K / $120KInvestors 29

Team

3 people
Camille Zenobia
CEO
Jamie Wolfer Saphow
Chief Technology Officer
Robert Saphow
CFO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 3 annual reports (FY2023–FY2025)

29 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 3, 20240001670254-24-000547
    EDGAR
  • Form CAug 8, 20230001670254-23-000753
    EDGAR
Source: ManualCIK 0001986576

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.